Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Zynerba Pharmaceuticals, Inc. (ZYNE) stock profile

Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.

Key facts

SymbolZYNE
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOArmando Anido MBA
Employees25
HeadquartersDevon, PA, US
IPO2015-08-05
Websitewww.zynerba.com

Explore ZYNE on Vantafin

  • Zynerba Pharmaceuticals, Inc. Overview
  • Zynerba Pharmaceuticals, Inc. Financials
  • Zynerba Pharmaceuticals, Inc. Events
  • Zynerba Pharmaceuticals, Inc. SEC filings
  • Zynerba Pharmaceuticals, Inc. Insider transactions
  • Zynerba Pharmaceuticals, Inc. Transcripts

Frequently asked questions

What does Zynerba Pharmaceuticals, Inc. (ZYNE) do?
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Where is ZYNE stock listed?
Zynerba Pharmaceuticals, Inc. trades under the ticker ZYNE on NASDAQ.
How can I research ZYNE's financials and filings?
Vantafin provides Zynerba Pharmaceuticals, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the ZYNE profile.